Detalles de la búsqueda
1.
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
Emerg Infect Dis
; 25(8): 1511-1521, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31298654
2.
One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.
BMC Vet Res
; 11: 92, 2015 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25880646
3.
Rhythmic profile of memory T and B-cells along childhood and adolescence.
Sci Rep
; 13(1): 20978, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38017254
4.
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine
; 40(5): 798-810, 2022 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34969545
5.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 2433, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31695694
6.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Front Immunol
; 10: 2192, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31616412
7.
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 1211, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293563
8.
The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.
Expert Rev Vaccines
; 17(1): 79-90, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29172832
9.
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.
PLoS Negl Trop Dis
; 12(6): e0006462, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29879134
10.
Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
J Immunol Methods
; 448: 9-20, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28514646
11.
Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes.
Vet Parasitol
; 220: 33-45, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26995719
12.
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Hum Vaccin Immunother
; 12(2): 491-502, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26360663
13.
Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining.
Acta Vet Scand
; 57: 51, 2015 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26362860
14.
Resultados
1 -
14
de 14
1
Próxima >
>>